Adaptimmune Therapeutics plc earnings per share and revenue

ADAP earnings per share for the last quarter are 0.04 USD whereas the estimation was -0.04 USD which accounts for 191.30% surprise. Company revenue for the same period amounts to 128.23 M USD despite the estimated figure of 40.47 M USD. Estimated earnings per share for the next quarter are -0.01 USD, and revenue is expected to reach 18.96 M USD. Also watch annual changes over time to get a bigger picture of ADAP earnings per share and revenue dynamics.